Clinical trial

Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

NCT04850937

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Esketamine Normalized identity: esketamineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention normal saline Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-02-10

PhaseNA

Conditions

Depressionverified · MONDO: depressive disorder

Interventions

EsketamineDRUG · verified · RxNorm: esketamine

normal salineDRUG

Sponsors & collaborators

Yangzhou Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04850937 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.